K51.9
Conditions
Interventions
Group 1: This observational study will be performed in a prospective, 24-month follow-up, noninterventional format in UC patients. Patients will be asked to complete five short questionnaires or visua
Sponsors
AbbVie Deutschland GmbH & Co. KG
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Patients aged = 18 years who have been diagnosed with Ulcerative Colitis = 12 months prior to study inclusion • Signed a patient authorization form to use and disclose personal health information
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| • To evaluate Pictorial Representation of Illness and Self Measure (PRISM) as an assessment tool for perceived disease-associated suffering in UC patients, by assessing correlation with Short quality of life in inflammatory Bowel Disease Questionnaire (SIBDQ) and Patient Health Questionnaire (PHQ-9) (quality of life), according to geographical location and disease severity. | — |
Secondary
| Measure | Time frame |
|---|---|
| • To describe the multi-faceted burden of disease in recently diagnosed Ulcerative Colitis patients. | — |
Countries
Argentina, Austria, Bosnia & Herzegovina, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Egypt, Estonia, France, Germany, Greece, Ireland, Israel, Italy, Japan, Kuwait, Mexico, Portugal, Romania, Russia, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Turkey, Ukraine, United Kingdom, Venezuela
Contacts
Public ContactStefan Rath
AbbVie Deutschland GmbH & Co. KG
Outcome results
None listed